Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,605Revenue (TTM) $M186Net Margin (%)-17.0Altman Z-Score1.6
Enterprise Value $M4,843EPS (TTM) $-0.2Operating Margin %-73.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-16.1Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio3.2Cash flow > EarningsN
Price/Sales24.55-y EBITDA Growth Rate %--Current Ratio3.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-5.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M194ROIC % (ttm)-99.8Gross Margin Increase y-yY

Gurus Latest Trades with ARIA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
ARIAMichael Price 2016-09-30 Reduce-0.13%$7.03 - $14.14
$ 23.75137%Reduce -12.56%940,000
ARIAJoel Greenblatt 2016-09-30 Buy 0.03%$7.03 - $14.14
$ 23.75137%New holding154,887
ARIAMichael Price 2016-03-31 Add0.23%$4.48 - $6.66
$ 23.75324%Add 31.10%1,075,000
ARIAMichael Price 2015-12-31 Add0.08%$5.78 - $7.19
$ 23.75261%Add 14.45%820,000
ARIAMichael Price 2015-09-30 Add0.15%$5.81 - $9.89
$ 23.75208%Add 30.27%716,500
ARIAJoel Greenblatt 2015-06-30 Sold Out $7.9 - $9.71
$ 23.75169%Sold Out0
ARIAMichael Price 2015-03-31 Buy 0.6%$6.1 - $8.97
$ 23.75221%New holding550,000
ARIAJoel Greenblatt 2015-03-31 Buy $6.1 - $8.97
$ 23.75221%New holding16,344
ARIAGeorge Soros 2014-12-31 Sold Out -0.01%$5.02 - $7.46
$ 23.75278%Sold Out0
ARIAGeorge Soros 2014-09-30 Reduce-0.04%$5.01 - $6.5
$ 23.75307%Reduce -85.00%150,000
ARIAGeorge Soros 2014-06-30 Add0.02%$6.3 - $8.52
$ 23.75245%Add 100.00%1,000,000
ARIAGeorge Soros 2014-03-31 Reduce-0.08%$6.46 - $8.99
$ 23.75206%Reduce -74.36%500,000
ARIAGeorge Soros 2013-12-31 Buy 0.11%$2.2 - $18.8
$ 23.75360%New holding1,950,000
ARIAGeorge Soros 2012-06-30 Sold Out -0.15%$14.6 - $17.82
$ 23.7545%Sold Out0
ARIAGeorge Soros 2012-03-31 Buy 0.15%$12.73 - $16.32
$ 23.7573%New holding635,000
ARIAGeorge Soros 2011-12-31 Sold Out -0.07%$8.03 - $12.5
$ 23.75117%Sold Out0
ARIAGeorge Soros 2011-09-30 Buy 0.07%$7.63 - $13.34
$ 23.75125%New holding496,847
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARIA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

ARIA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2017-01-09Sell32,000$23.78-0.29view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-10-24Sell19,638$9.56148.01view
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2016-10-03Sell47,384$13.4676.15view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-09-28Sell8,750$13.9869.6view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-09-22Sell20,000$13.4376.55view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-09-15Sell59,369$11.73102.13view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-08-22Sell19,436$10.47126.46view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-08-12Sell25,000$10.5125.81view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-07-22Sell18,286$8.11192.36view
Cole Hugh MSVP, Chief Business Officer 2016-06-28Sell6,012$7.05236.31view

Quarterly/Annual Reports about ARIA:

News about ARIA:

Articles On GuruFocus.com
Michael Price Invests in 11 Companies in First Quarter May 19 2015 
Sarah Ketterer of Causeway Capital's Answers to GuruFocus Q&A Apr 07 2014 
Weekly CEO Sells Highlight: U.S. Bancorp, Restoration Hardware Holdings Inc, Ariad Pharmaceuticals, Jul 20 2013 
Daniel Loeb's Top Three Increases of the First Quarter May 24 2013 
Weekly CFO Sales Highlight: WWWW, FIO, CRIS, ARIA, VOG, APKT Apr 22 2012 
3 Biotech Stocks To Consider Buying Right Now Jan 10 2012 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 10 2009 
Weekly CEO Buys Highlight: Citigroup Inc, ARIAD Pharmaceuticals Inc, Bruker BioSciences Corp, Akamai Aug 08 2009 

More From Other Websites
Ariad Put Off Potential Suitor Amid 'Aggressive' Takeda Bid: RBC Jan 20 2017
Ariad played hardball to boost Takeda buyout price, federal filings show Jan 20 2017
Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017 Jan 20 2017
Can The Uptrend Continue for ARIAD Pharmaceuticals (ARIA)? Jan 20 2017
Takeda Commences Cash Tender Offer for All Outstanding Shares of ARIAD Pharmaceuticals, Inc. Jan 19 2017
Ariad Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of ARIA Shareholders Jan 18 2017
Jazz Begins Phase III Study for Label Expansion of Defitelio Jan 18 2017
Becton, Dickinson Commercially Launches Precise WTA Kits Jan 18 2017
ARIAD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of ARIAD Pharmaceuticals,... Jan 13 2017
ArQule (ARQL) Catches Eye: Stock Moves 7.2% Higher Jan 13 2017
ARIAD: Acquisition by Takeda Bodes Well, Competition a Risk Jan 13 2017
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ARIAD... Jan 12 2017
Ariad Pharm downgraded by SunTrust Jan 11 2017
Former Ariad CEO Berger says Takeda deal was 'merely a matter of time' Jan 11 2017
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jan 10 2017
Ariad Pharmaceuticals Cash Acquisition by Takeda Pharmaceuticals Could a Second Buyer Surface Jan 10 2017
Takeda deal results in a huge windfall for former Ariad CEO Harvey Berger Jan 10 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)